CME/CE
Popular
Nadia Harbeck, MD, PhD
- MinuteCE®
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Amir T. Fathi, MD
Courtney DiNardo, MD
Brian A. Jonas, MD, PhD
Shubham Pant, MD, MBBS
Ritu Salani, MD, MBA
Shubham Pant, MD, MBBS
Ritu Salani, MD, MBA
Ritu Salani, MD, MBA
- Project Oncology®
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Saad Z. Usmani, MD, MBA, FACP
Joshua Richter, MD
Ashley Steinberger, APP
Jennifer Caudle, DO
Patricia A. Mangan, RN, MSN, APRN-BC
- Project Oncology®
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
Jesus G. Berdeja, MD
Nicholas G. Barkemeyer, MPAS
Ajai Chari, MD
Harvey Church
Amy Gebhardt
Steven Morrow
Elizabeth Montgomery, MD
John L. Marshall, MD
- CME/CE Broadcast Replay
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
1.00 creditJennifer Caudle, DO
Patricia A. Mangan, RN, MSN, APRN-BC
- MinuteCE®
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
1.25 program creditsSamuel J. Klempner, MD
- Project Oncology®
Tailoring Treatment Plans for HER2+ Metastatic Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
Saranya Chumsri, MD